Skip to main content

Peter Grimison

Jul 20, 2026

21:48
Is there any immunotherapy agents out there or on the horizon?
21:53
Well, it's coming through and you may be aware that on the PBS in Australia now, you can use immunotherapy for any advanced or metastatic cancer that deem to be immunotherapy sensitive.
22:09
So suddenly the sarcoma community have the opportunity to use immunotherapy to And we've really got to decide what is an immunotherapy sensitive cancer.
22:19
Now, if it's lung cancer or melanoma, there's enormous phase three trials showing a benefit.
22:25
But for all these ultra rare coma subtypes, there's not a lot of evidence.
22:30
So we need to decide if on a small phase two trial, is it worthwhile? But there is, we contributed to an international trial of adding immunotherapy to radiation before surgeries curative soft tissue sarcoma.
22:47
Australia contributed the largest number of patients internationally.
26:13
What are some of the common questions you get with patients?
21:48
Is there any immunotherapy agents out there or on the horizon?
21:53
Well, it's coming through and you may be aware that on the PBS in Australia now, you can use immunotherapy for any advanced or metastatic cancer that deem to be immunotherapy sensitive.
22:09
So suddenly the sarcoma community have the opportunity to use immunotherapy to And we've really got to decide what is an immunotherapy sensitive cancer.
22:19
Now, if it's lung cancer or melanoma, there's enormous phase three trials showing a benefit.
22:25
But for all these ultra rare coma subtypes, there's not a lot of evidence.
22:30
So we need to decide if on a small phase two trial, is it worthwhile? But there is, we contributed to an international trial of adding immunotherapy to radiation before surgeries curative soft tissue sarcoma.
22:47
Australia contributed the largest number of patients internationally.
26:13
What are some of the common questions you get with patients?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.